Compare Heron Therapeutics Inc (HRTX) vs Packaging Corporation of America (PKG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Packaging Corporation of America — how do they compare? Heron Therapeutics Inc trades at $0.48 (market cap $91.46M), while Packaging Corporation of America trades at $227.88 (market cap $20.77B). The key difference: Packaging Corporation of America is far larger — about 227.1× Heron Therapeutics Inc's market cap, and Packaging Corporation of America pays a 2.57% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | PKG | |
|---|---|---|
Market Cap | $91.46M | $20.77B |
Sector | Health | Technology |
52-Week High | $1.96 | $246.31 |
52-Week Low | $0.39 | $191.41 |
Enterprise Value | $189.36M | $24.59B |
Dividend Yield | — | 2.57% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.
Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.
Packaging Corporation of America (PKG) trades at $228.43, down 1.99% today, with mixed technical signals showing bullish moving averages but neutral oscillators. The company reported Q1 2026 EPS of $2.40, beating estimates, but faces margin pressure with net income expected to decline to $741 million in 2026. Recent developments include a 20% dividend increase and upcoming Q2 earnings on July 22, 2026.
PKG presents a balanced outlook with strong institutional support and dividend growth offset by earnings volatility and margin compression. The consensus price target of $256.14 suggests 12% upside potential, but investors should monitor Q2 results and cost management amid inflationary pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Packaging Corporation of America
Packaging Corporation of America is a leading producer of containerboard and corrugated packaging products in North America. The company also produces white papers, which include printing and writing papers. PKG operates as an integrated manufacturer, with a strong focus on high-quality and sustainable packaging solutions for e-commerce, food and beverage, and other industrial and consumer markets.
Read more on PKG →
